داروپخش
وپخش | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Authorized
Last Price: 53,660 2.98
Close Price: 53,680
Income Statement
AGM
Interim
2026/08/22 Fiscal Year 2026/03/2012 Month | 2025/07/22 Fiscal Year 2025/03/2012 Month | 2024/07/20 Fiscal Year 2024/03/1912 Month | ||
|---|---|---|---|---|
Revenue from Services & Sales | - | 13.609 Trillion | 12.126 Trillion | |
Total Revenues | 32.28 Trillion | 13.609 Trillion | 12.126 Trillion | |
Gross Profit | 32.28 Trillion | 13.609 Trillion | 12.126 Trillion | |
General & Administrative Expenses | 408.429 Billion | 252.097 Billion | 148.567 Billion | |
Operating Profit (Loss) | 31.871 Trillion | 13.357 Trillion | 11.977 Trillion | |
Profit Before Tax | 31.92 Trillion | 15.283 Trillion | 12.038 Trillion | |
Tax | 824 Million | 11.913 Billion | - | |
Net Profit (Loss) After Tax | 31.92 Trillion | 15.271 Trillion | 12.038 Trillion | |
Retained Earnings at Beginning of Period | 19.835 Trillion | 16.501 Trillion | 27.811 Trillion | |
Approved Dividends — Prior Year AGM | -12.096 Trillion | -10.08 Trillion | -22.863 Trillion | |
Allocable Profit | 39.658 Trillion | 21.692 Trillion | 16.986 Trillion | |
Legal Reserve | - | - | 485 Billion | |
Other Reserves | 12.147 Billion | 1.857 Trillion | 171 Million | |
Approved Dividends — Current Year | 28.728 Trillion | 12.096 Trillion | 10.08 Trillion | |
Retained Earnings at End of Period | 10.918 Trillion | 7.739 Trillion | 6.421 Trillion | |
سود حاصل از سرمایه گذاریها | 32.28 Trillion | - | - |